 |
2006-10-27 News Release
Accelerator solutions
designed to help pharmaceutical companies
BASF will showcase Accelerator solutions designed to help pharmaceutical
companies to be more successful at the AAPS exposition.
See BASF showcasing “Accelerator” solutions at the American
Association of Pharmaceutical Scientists
(AAPS) exposition, Oct. 29 to Nov. 2, at the Henry B. Gonzalez Convention
Center in San Antonio, Texas.
Find
Information and Suppliers of pharmaceutical ingredients.
Featured at BASF Booth 626 are:
· innovative excipients and active ingredients that accelerate
the functionality of pharmaceuticals, and
· contract manufacturing services, exclusive custom synthesis
and experienced technical staff with industry specific formulation
expertise that can help accelerate products to market.
Among the new products is a direct compression grade ibuprofen powder
that can help pharmaceutical companies to streamline manufacturing processes.
|
Ibuprofen tablet testing,
Shreveport, La. site. Click
Go for High resolution image. photo: BASF
|
|
BASF’s new Ibuprofen DC 85 can help pharmaceutical companies to
eliminate steps associated with wet granulation and compaction processes
currently employed for typical ibuprofen powders. BASF plans to file a
Drug Master File (DMF) for Ibuprofen DC 85 with the U.S.
Food and Drug Administration
by the first quarter of 2007.
BASF will also showcase its portfolio of new excipients including:
· Kollidon* VA-64 Fine, which delivers advanced performance as
dry binder for direct compression and roller compaction;
· Kollidon* CL-F which is particularly suited for the manufacture
of very small tablets; and,
· Kollidon* CL-SF which helps tablets disintegrate quickly to increase
the bioavailability of active pharmaceutical ingredients
(APIs).
“The ‘Accelerator’ theme represents BASF’s ability
to blend ingredients, formulation support, research and development capabilities
and full service manufacturing facilities into enabling solutions that
can help our customers make their products better along the pharmaceutical
value chain,” said Folker Ruchatz, Ph.D., Director of BASF’s
Pharma Solutions and Dietary Supplements business in North America.
Anisul Quadir, Ph.D., Technical Services Manager, Pharma Solutions and
Dietary Supplements for BASF in North America, will participate in a Pharmaceutical
Technologies symposium titled “Role of Excipients in Modification
of Drug Release Profile and Bioavailability of Finished Dosage Forms”
on Thursday, Nov. 2. Dr. Quadir’s presentation is titled “Application
of Micronized Poloxamer in Pharmaceutical Development.”
BASF builds on broad expertise in excipients, chemistry research capabilities,
and strategic investment in new technologies to serve customers in the
pharmaceutical industry. With more than 60 years of experience in polymer
chemistry, BASF offers a range of excipients, including solubilizers,
surfactants, coatings and binders. BASF also offers active ingredients,
exclusive custom synthesis and contract manufacturing solutions, plus
the services of an experienced technical services staff with pharmaceutical
formulation expertise.
Find more information about BASF.
Read a recent press release about - A milestone for BASF by becoming the
global market leader in the field of chromate free corrosion
protection for steel and aluminum coil coatings applications.
Pharma
Jobs - Post Employment Opportunity!
Click
here to view more news headlines.
E-mail this page to a friend 
|
|
News / Resources
- Genetically
enhanced tomatoes could reduce cardiovascular disease
- Certification, Training and Courses
from The American Management Association
- Small
quantities Fast - Plastics, Metals, Tool Steel and ...
-
Looking for a Study Program?
- All this Months News
- Changing Jobs? View
Homes for Sale in the U.S.
- Buy Golf Equipment Direct
from the Manufacturer and Save!
- Maybe
it's time to check your Homeowners
Copyright
- Unless otherwise
stated all contents of this web site are © 1998/2006 JOBWERX.COM.
|
